Soares; M. Melina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Soares; M. Melina.The latest application filed is for "methods for treating diseases and hsv using antibodies to aminophospholipids".

Company Profile

0.7.11

Soares; M. Melina - Bangalore IN
Soares; M. Melina - Richardson TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for Treating Diseases and HSV Using Antibodies to Aminophospholipids App 20130243756 - Thorpe; Philip E. ; et al.	2013-09-19
Compositions and Methods Comprising Phosphatidylethanolamine-Binding Peptide Derivatives App 20120164071 - Thorpe; Philip E. ; et al.	2012-06-28
Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids App 20120064037 - Thorpe; Philip E. ; et al.	2012-03-15
Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids Grant 7,906,115 - Thorpe , et al. March 15, 2	2011-03-15
Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids Grant 7,790,159 - Thorpe , et al. September 7, 2	2010-09-07
Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids Grant 7,611,704 - Thorpe , et al. November 3, 2	2009-11-03
Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents Grant 7,511,124 - Thorpe , et al. March 31, 2	2009-03-31
Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids Grant 7,455,833 - Thorpe , et al. November 25, 2	2008-11-25
Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents Grant 7,384,909 - Thorpe , et al. June 10, 2	2008-06-10
Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives Grant 7,378,386 - Thorpe , et al. May 27, 2	2008-05-27
Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents App 20050059578 - Thorpe, Philip E. ; et al.	2005-03-17
Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents App 20050025761 - Thorpe, Philip E. ; et al.	2005-02-03
Methods for treating viral infections using immunoconjugates to aminophospholipids App 20040213779 - Thorpe, Philip E. ; et al.	2004-10-28
Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives App 20040214764 - Thorpe, Philip E. ; et al.	2004-10-28
Compositions for treating viral infections using immunoconjugates to aminophospholipids App 20040161429 - Thorpe, Philip E. ; et al.	2004-08-19
Methods for treating viral infections using antibodies to aminophospholipids App 20040131610 - Thorpe, Philip E. ; et al.	2004-07-08
Combinations and kits for treating viral infections using antibodies to aminophospholipids App 20040131621 - Thorpe, Philip E. ; et al.	2004-07-08
Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids App 20040131622 - Thorpe, Philip E. ; et al.	2004-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.